BOTOX® (onabotulinumtoxinA)

Tagline Brand's website · 2026-10-04

Unparalleled brand recognition, extensive clinical research and FDA approvals across numerous indications, a long history of safety and efficacy, and a widespread network of trained practitioners. It is often seen as the 'original' and most trusted neurotoxin brand.

Description Brand's website · 2026-10-04

Botox, short for Botulinum Toxin Type A, is a neurotoxin protein produced by the bacterium Clostridium botulinum. It is primarily known for its cosmetic applications in temporarily reducing facial wrinkles and fine lines. Beyond aesthetics, it is also approved for various therapeutic medical conditions, including chronic migraine, severe primary axillary hyperhidrosis (excessive sweating), cervical dystonia, blepharospasm, and spasticity. It works by blocking nerve signals to muscles, causing them to relax.

Core capabilities Brand's website · 2026-10-04

• Botulinum Toxin Type A (Botox Cosmetic
• Botox Therapeutic)

Pricing Brand's website · 2026-10-04

Medical professionals purchase Botox vials from Allergan (AbbVie). Pricing to the end-consumer is typically per unit or per area treated, determined by the administering clinic or practitioner.

Target industry Brand's website · 2026-10-04

Individuals seeking aesthetic improvements (wrinkle reduction), patients with chronic migraines, severe hyperhidrosis, muscle spasticity, cervical dystonia, and blepharospasm.

Competitors Brand's website · 2026-10-04

• Dysport (Galderma)
• Xeomin (Merz Aesthetics)
• Jeuveau (Evolus)
• Daxxify (Revance Therapeutics)